To assess the potential functional impact of PSPC1 and TGFβ activation in patients with OSA when they develop a tumor, we used an in vitro model of melanoma cells, given that melanoma aggressiveness is clearly elevated in these patients [1,54]. This evidence concerns the gene PSPC1 and neoplasm.